Loading...
Plavix
Antiplatelet • P2Y12 inhibitor
Prodrug that irreversibly inhibits P2Y12 ADP receptor on platelets
Drug Class
Antiplatelet
Subclass
P2Y12 inhibitor
Half-life
6 hours
Time for plasma concentration to decrease by 50%
Protein Binding
98%
Fraction bound to plasma proteins
Therapeutic Index
Wide
Margin between therapeutic and toxic doses